{"id":"W2659827805","doi":"10.1200/jco.2017.35.15_suppl.e12538","title":"Real world experience with exemestane and everolimus for advanced HR-positive breast cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Exemestane; Everolimus; Internal medicine; Metastatic breast cancer; Breast cancer; Cohort; Oncology; Adverse effect; Population; Cancer; Progression-free survival; Toxicity; Letrozole; Aromatase inhibitor; Chemotherapy; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002202377,0.0001504302,0.0003249987,0.0001681024,0.000480248,0.0006754562,0.0004271358,0.0003965136,0.004558415],"category_scores_gemma":[0.004393198,0.0001438577,0.0004822642,0.000339748,0.0003281613,0.0006311484,0.0009719094,0.0005883483,0.000783889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001223595,"about_ca_system_score_gemma":0.000834782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002378916,"about_ca_topic_score_gemma":0.004055099,"domain_scores_codex":[0.9990552,0.0005040425,0.00008422681,0.00008920319,0.0001538885,0.0001135035],"domain_scores_gemma":[0.998229,0.0005111445,0.0004908367,0.00009054699,0.00008971263,0.0005887132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03928992,0.008136298,0.4164421,0.001680554,0.0006643607,0.005321783,0.003518581,0.002376996,0.003824959,0.0008464534,0.02311747,0.4947805],"study_design_scores_gemma":[0.01695378,0.0878434,0.6301832,0.0008401095,0.0007664594,0.0179089,0.003583696,0.002436823,0.003478964,0.0007871668,0.235082,0.0001354222],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9769251,0.00972102,0.0003251829,0.002788526,0.00009251809,0.0002607166,0.0009358354,0.00002850175,0.008922632],"genre_scores_gemma":[0.9893366,0.004890618,0.0005578076,0.001308156,0.0001935309,0.0001484813,0.001199382,0.00001824634,0.002347258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004558415,"threshold_uncertainty_score":0.01524943,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08937730650384973,"score_gpt":0.5096555776797362,"score_spread":0.4202782711758865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}